Bellerophon Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
03 Apr 2023	Form 3: Kim Bobae, VP Reg. Affairs & Quality Holds 9,890 shares of Common Stock
08 Oct 2021	Form 3: Laccona Nicholas, Controller, (PFO & PAO)
11 Sep 2020	Form 3: Fares Wassim, Chief Medical Officer No securities owned
27 Mar 2019	Form 3: Teufel Crispin, Director No securities owned
16 Aug 2018	Form 3: Venrock Associates Iv L P, 10% owner and 1 other Holds 6,011,793 shares of Common Stock
16 Aug 2018	Form 3: Venrock Associates Iv L P, 10% owner and 9 others Holds 6,011,793 shares of Common Stock
30 Mar 2018	Form 3: Bennett Matthew, Director Holds 18,565 shares of Common Stock
17 Jan 2018	Form 3: Korner Assaf, CFO No securities owned
04 Dec 2017	Form 3: Wang Theodore T, Director Holds 8,298,755 shares of Common Stock
05 Oct 2017	Form 3: Puissance Cross-Border Opportunities Iii Llc, 10% owner and 4 others Holds 8,298,755 shares of Common Stock
16 Mar 2017	Form 3: Schoeps Megan, Principal Financial Officer Holds 4,668 shares of Common Stock
04 May 2016	Form 3: Shah Parag Suresh, VP Proj Mgmt & Distribution Holds 13,554 shares of Common Stock
01 Mar 2016	Form 3: Tenenbaum Fabian, CFO & Chief Business Officer No securities owned
16 Feb 2016	Form 3: Cloyd Mary Ann, Director No securities owned
23 Oct 2015	Form 3: Edmonds Amy, VP Clinical Operations & Admin
23 Oct 2015	Form 3: Quinn Deborah, Chief Medical Officer
13 Jul 2015	Form 3: Agrawal Amit, Chief Operating Officer No securities owned
01 Jul 2015	Form 3: Amin Naseem, Director No securities owned
22 May 2015	Form 3: Dekker Martin, VP of Device Engineering
20 May 2015	Form 3: Fernandes Peter, Chief Regulatory Officer Holds 2,395 shares of Common Stock

Comments